Increasing infectious disease prevalence, an increase in the geriatric population, an increase in the prevalence of lifestyle-related diseases, an increase in healthcare expenditure, an increase in healthcare awareness through campaigns and conferences, and an increase in the number of initiatives by various governments and government associations are some of the key factors driving the growth of the global point-of-care infectious disease diagnostics. It entails performing a test close to the site of patient care in order to provide immediate results, outside of the traditional laboratory environment. Tuberculosis, HIV, hepatitis, influenza, sexually transmitted infections, and tropical diseases such as dengue fever and malaria are among the major diseases that can be tested using point-of-care testing devices. Rapid diagnosis of an infection benefits patients by facilitating timely access to care and also reduces the likelihood of disease transmission. Furthermore, point-of-care tests aid in the management of infectious diseases in settings where access to quality and timely medical care is limited. Recent advancements in healthcare delivery and diagnostic technology have resulted in an increase in demand for POCT in primary and community care settings.